LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

LAVA Therapeutics NV
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Pre-Tax Income
-$24.5m
CAGR 3-Years
18%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Pre-Tax Income
$14.8m
CAGR 3-Years
-36%
CAGR 5-Years
-21%
CAGR 10-Years
7%
ProQR Therapeutics NV
NASDAQ:PRQR
Pre-Tax Income
-€42.6m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
-10%
Uniqure NV
NASDAQ:QURE
Pre-Tax Income
-$224.7m
CAGR 3-Years
-21%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
argenx SE
XBRU:ARGX
Pre-Tax Income
$85.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Pre-Tax Income
-$369.8m
CAGR 3-Years
-80%
CAGR 5-Years
-35%
CAGR 10-Years
-30%
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Pre-Tax Income?
Pre-Tax Income
-24.5m USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Pre-Tax Income amounts to -24.5m USD.

What is LAVA Therapeutics NV's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-20%

Over the last year, the Pre-Tax Income growth was 41%. The average annual Pre-Tax Income growth rates for LAVA Therapeutics NV have been 18% over the past three years , -20% over the past five years .

Back to Top